Zobrazeno 1 - 10 of 198 pro vyhledávání: '"F. Rodeghiero and"'
1
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC
Autor: F. Rodeghiero, V. De Stefano, Cristina Santoro, Sergio Siragusa, Nicola Vianelli, Francesco Zaja, Federico Chiurazzi, Giuseppe Carli, Monica Carpenedo, Valentina Carrai, Silvia Cantoni
Publikováno v: Mediterranean Journal of Hematology and Infectious Diseases. 13
The current COVID-19 pandemic requires revisiting our current approach to major blood disorders, including ITP (Immune Thrombocytopenia), stirring up the production of several disease-specific practical guidelines. This report describes an updated ve
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::71a332113c09ba6dfa1e4a59083327d9
https://doi.org/10.4084/mjhid.2021.032
Zobrazit plný text záznamu
2
Thrombopoietin receptor agonists in hereditary thrombocytopenias
Autor: F. Rodeghiero, Carlo L. Balduini, Alessandro Pecci
Publikováno v: Journal of thrombosis and haemostasis : JTH. 16(9)
Hereditary thrombocytopenias (HTPs) constitute a heterogeneous group of diseases characterized by a reduction in platelet count and a potential bleeding risk. As a result of advances in diagnostic methods, HTPs are increasingly being identified, and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::989769fb01b88bbbb44380569a0c6f43
https://pubmed.ncbi.nlm.nih.gov/29956472
Zobrazit plný text záznamu
6
The dilution of vanadyl pyrophosphate, catalyst for n-butane oxidation to maleic anhydride, with aluminum phosphate: unexpected reactivity due to the contribution of the diluting agent
Autor: Alessandra Frattini, Carlo Fumagalli, Ferruccio Trifiro, M. Ricotta, Gianluca Mazzoni, F. Rodeghiero, G. Puccinotti, Fabrizio Cavani, Carlotta Cortelli
Publikováno v: Topics in Catalysis. 38:295-301
This paper describes the preparation, characterization and reactivity in n-butane oxidation of catalysts made of vanadyl pyrophosphate (VPP) diluted in aluminum phosphate. Catalysts were prepared by synthesizing at the same time the VPP precursor and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::309a1af44e55fb18e5cb59268671147b
https://doi.org/10.1007/s11244-006-0028-3
Zobrazit plný text záznamu
7
Bleeders, bleeding rates, and bleeding score
Autor: Alberto Tosetto, Giancarlo Castaman, F. Rodeghiero
Publikováno v: Journal of Thrombosis and Haemostasis. 11:142-150
Bleeding symptoms are frequently reported even in otherwise healthy subjects, and differentiating a normal subject from a patient with a mild bleeding disorder (MBD) can be extremely challenging. The concept of bleeding rate, that is, the number of b
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bf640de7950f333226c92ed17af5b71
https://doi.org/10.1111/jth.12248
Zobrazit plný text záznamu
8
Acquired haemophilia: experience of two Italian centres with 17 new cases
Autor: N. Ciavarella, F. Rodeghiero, Mario Schiavoni, Giancarlo Castaman, E. Di Bona
Publikováno v: Haemophilia : the official journal of the World Federation of Hemophilia. 3(3)
Summary. Acquired haemophilia is a rare but often catastrophic haemorrhagic disorder associated with a high mortality rate. No single therapeutic approach has been consistently successful and clinical experience remains mainly anecdotal. This report
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc92203797cd31221128151799918380
https://pubmed.ncbi.nlm.nih.gov/27214802
Zobrazit plný text záznamu
9
Reduced von Willebrand factor secretion is associated with loss of Weibel–Palade body formation
Autor: F. Rodeghiero, Sandra L. Haberichter, U. Budde, Giancarlo Castaman, Reinhard Schneppenheim, Paula M. Jacobi, Tobias Obser, Sofia H. Giacomelli
Publikováno v: Journal of Thrombosis and Haemostasis. 10:951-958
Summary. Background: von Willebrand disease (VWD) is caused by mutations in von Willebrand factor (VWF) that have different pathophysiologic effect in causing low plasma VWF levels. Type 1 VWD includes quantitative plasma VWF deficiency with normal V
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a83b46fe722b3e80b63405f8f35a5a6
https://doi.org/10.1111/j.1538-7836.2012.04702.x
Zobrazit plný text záznamu
10
Hematologic malignancies and thrombosis
Autor: F. Elice, F. Rodeghiero
Publikováno v: Thrombosis Research. 129:360-366
Patients with hematologic malignancies have an increased risk of venous thromboembolism (VTE), particularly at diagnosis and during the treatment with chemotherapy, asparaginase or immunomodulatory drugs (IMiDs). A disease-dependent hypercoagulable c
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::208ef65dc7e37d14de77bf3a2538c325
https://doi.org/10.1016/j.thromres.2011.11.034
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje